Myriad Genetics Announces Reorganization of European Operations and Sale of EndoPredict Business June 14, 2024 SALT LAKE CITY, May 07, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the... Continue Reading